https://pipelinereview.com/transgene-announces-collaboration-with-merck-kgaa-darmstadt-germany-and-pfizer-to-evaluate-the-combination-of-tg4001-with-avelumab-in-hpv-positive-head-neck-cancer-in-a-phase-1-2-study/
Transgene Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate the Combination of TG4001 with Avelumab in HPV-Positive Head & Neck Cancer in a Phase 1/2 Study